• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER INC QDOT MICRO; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER INC QDOT MICRO; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION Back to Search Results
Catalog Number D139505
Medical Device Problem Code Patient Device Interaction Problem (4001)
Health Effect - Clinical Code Heart Failure/Congestive Heart Failure (4446)
Date of Event 02/10/2026
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer's reference number: (b)(4).
 
Event or Problem Description
It was reported that a patient underwent an atrial fibrillation (afib) ablation procedure with a qdot micro and experienced cardiac failure.The report indicated that at the end of the afib case, the patient's statistics (stats) were low, along with low blood pressure.The patient was diagnosed with acute biventricular failure at the end of the case.The acute biventricular failure was confirmed using transesophageal echocardiogram (tee).The patient was confirmed to have no pericardial effusion with the tee.The patient was moved to intensive care unit (icu).The last known patient status was stable.Prior to ablation procedure, at the beginning of the afib case with rapid ventricular response (rvr), the patient was cardioverted and the procedure was completed with a qdot micro catheter.The physician¿s opinion on the cause of this adverse event was that it was due to the patient¿s afib with rvr and cardioversion and did not think that it had anything to do with a biosense webster inc.(bwi) product that was used.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
QDOT MICRO
Common Device Name
CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION
Manufacturer (Section D)
BIOSENSE WEBSTER INC
31 technology drive, suite 200
irvine CA 92618
Manufacturer (Section G)
BIOSENSE WEBSTER INC (JUAREZ)
circuito interior norte
1820parque industrial salvacar
juarez 32599
MX   32599
Manufacturer Contact
henry boden
31 technology dr
irvine, CA 92618
9497882078
MDR Report Key24551124
Report Number2029046-2026-00758
Device Sequence Number15824083
Product Code OAE
UDI-Device Identifier10846835016758
UDI-Public(01)10846835016758(11)251001(17)280930(10)31769176L
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
P210027
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date (Section B) 03/09/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Catalogue NumberD139505
Device Lot Number31769176L
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 02/10/2026
Initial Report FDA Received Date03/09/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured10/01/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
CARTO 3 SYSTEM.; NGEN PUMP, US CONFIGURATION.; NGEN RF GENERATOR, US.
Outcome Attributed to Adverse Event Required Intervention; Hospitalization;
Patient Age66 YR
Patient SexMale
Patient Weight105 KG
-
-